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Serum amyloid A4 (SAA4) is a constitutive apolipoprotein of high-density lipoprotein. It exhibits N-linked glycosylation in its
second half. There are both glycosylated and nonglycosylated forms in plasma and the ratio of these two forms varies among
individuals. This study was conducted to examine the influence of genetic polymorphism of SAA4 on its glycosylation status. In 55
healthy subjects, SAA4 polymorphism was analyzed by PCR combined direct sequencing and its glycosylation status was analyzed
by immunoblotting. The results showed that the percentage of glycosylation in subjects with amino acid substitutions at positions
71 and/or 84 was significantly (𝑃 < 0.05) higher than that in subjects with the wild type. The polymorphism had no influence on
theplasmaconcentrationofSAA4.Thesefindingssuggestthatthechangesinproteinstructuresaltertheefficiencyofglycosylation
in the SAA4 molecule. The functional implication of this should be of interest.
1. Introduction
Serum amyloid A (SAA) is a polymorphic protein [1–4]. In
humans, SAA proteins are coded at four loci, called SAA1,
SAA2, SAA3,a n dSAA4. SAA3 is a pseudogene, while the
others encode products, which are screted from the liver and
bound to high-density lipoprotein (HDL) in the blood. The
synthesis of SAA1 and SAA2 (acute phase SAA; A-SAA) is
increased in inflammatory disorders. They may play roles
in the immune system, lipoprotein metabolism, and tissue
repair during or subsequent to inflammation [2, 3]. They are
also serum precursors of AA proteins, the chief constituents
of reactive amyloid deposits [4]. Unlike A-SAA, SAA4,
constitutive SAA in other words, is not markedly elevated in
inflammationanddoesnotformamyloidfibrils[5–7],except
foritsvariant[8].SAA4has112aminoacids,withaninsertion
of eight amino acids at the position corresponding to residue
70 of A-SAA [5]. This insertion generates N-linked glyco-
sylation. Interestingly, SAA4 is not completely glycosylated;
two forms, glycosylated (G) and nonglycosylated (NG), are
observed in plasma (Figure 1). Since we noted that the ratio
of G:NG varies among individuals and might be constant
within individuals, this study aimed to examine whether the
glycosylation of SAA4 is genetically regulated.
2. Materials and Methods
2.1. Samples. The study protocol was approved by the Bioe-
thics Committee for Human Genome and Gene Analysis,
Jichi Medical University (No. 13–17). Fifty-two healthy adults
(22 females and 30 males), aged from 21 to 80, voluntarily
participated in this study. Since a rare polymorphism was
foundattwositesinafemale,herhusband,son,anddaughter
were added to the analyses. Blood was drawn into a tube
containing EDTA. After centrifugation, plasma was obtained
andkeptat−20
∘CandDN Awasextractedfromthebuffycoat
a n ds t o r e da t−20
∘C.
2.2. Immunoblotting. Plasma was diluted 1:100 with elec-
trophoresis sample buffer and 10𝜇Lo fi tw a ss u b j e c t e d
to tricine sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis followed by transfer to a polyvinyl difluoride
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Figure 1: Representative immunoblotting patterns for SAA4 in
plasma.Eachsa m pleo fpa t terns1,2,a nd3isfr o masub jectsho wing
S A A 4g e n o t y p ea st h ew i l dt y p e ,as u b s t i t u t i o na tp o s i t i o n7 1 ,
and substitutions at positions 71 and 84, respectively. Estimated
molecular weight is shown.
membrane, as previously described [7]. The membrane was
blocked in 1% bovine serum albumin (BSA) in phosphate-
buffered saline (PBS) for 1 hour at room temperature (RT)
andthenreactedwith2𝜇g/mLrabbitanti-humanSAA4anti-
bodies [9] for 1 hour at RT, followed by reaction with 1:1000-
diluted peroxidase-conjugated anti-rabbit immunoglobulins
(Bioscience Inc., USA) for 1 hour at RT. Then, as a substrate,
EzWestLumi plus (ATTO Corp., Japan) was applied and the
output was analyzed using a chemiluminescent image ana-
lyzer system, Ez-Capture MG (ATTO). Using CS Analyzer
3 . 0s o ft w a r ei nt h a ts y s t e m ,t h ei n t e n s i t i e so ft h et w oS A A 4 -
corresponding bands were read. The SAA4 concentration of
each sample was calculated from the intensities of the two
bands by comparison with those of the serum, the SAA4
concentration of which was known [9].
2.3. DNA Analysis. S A A 4e x o n s2 ,3 ,a n d4w e r es u b j e c t e d
to PCR followed by direct sequencing as previously repor-
ted [8]. This was performed on the selected subjects as
described below. On the basis of the SNPs found in exon 4,
PCR-RFLP methods were established for the screening anal-
ysis. PCR was performed for 30 cycles of 94
∘C, 1min; 54
∘C,
1min; and 72
∘C, 1min using a forward primer (CCAGG-
GTCTATCTTCAGGGATTAATAGAGT), which included
a restriction site and a reverse primer (TTCAGTATTTCT-
TAGGCAGGCCGTCAGGTC).DigestionwithAfaI(Takara,
Japan), which cuts the wild-type sequence at residue 71, or
TaqI (Takara), which cuts the wild-type sequence at residue
8 4 ,w a se v a l u a t e do na na g a r o s eg e l .
3. Results
Immunoblottingfindingswerelargely dividedintothreepat-
terns (Figure 1): pattern 1: nonglycosylated form (NG) domi-
nant (corresponding to percentage of glycosylation <40% in
Figure 3), pattern 3: glycosylated form (G) dominant (corre-
sponding to percentage of glycosylation >60% in Figure 3),
and pattern 2: intermediate between patterns 1 and 3. Out
of 52 subjects, 42 (80.8%), 6 (11.5%), and 4 (7.7%) showed
patterns 1, 2, and 3, respectively. A faint band was seen just
below the nonglycosylated SAA4 of pattern 3. It may have
corresponded to a posttranslationally C-terminus-degraded
species [10], although this was not confirmed.
DNA sequencing of the four exons was performed for
t w os u b j e c t si ne a c hg r o u ps h o w i n gt h ed i ff e r e n tp a t t e r n si n
71: Tyr/Tyr
84: Ser/Ser 
%G: 26.1
71: Tyr/Cys
84: Ser/Leu 
%G: 72.2
71: Tyr/Tyr
84: Ser/Leu 
%G: 50.1
71: Tyr/Tyr
84: Ser/Leu 
%G: 49.3
Figure 2: Family analysis of SAA4 polymorphism and the percent-
age of glycosylation (%G). Substituted amino acids are underlined.
e:p r o b a n ds h o w i n gt w os u b s t i t u t i o n s .
immunoblotting.Thedataforsubjectsshowingpattern1were
in complete agreement with a previous report [5]a n da r e
r e f e r r e dt oa st h ew i l dt y p eh e r e .S u b j e c t ss h o w i n gp a t t e r n
2 had an allele with a substitution at residue 71 from TAC
to TGC, which would change the amino acid from tyrosine
to cysteine. One out of the two subjects showing pattern 3
had an allele with a substitution at residue 84 from TCG to
TTG, which changes the amino acid from serine to leucine.
Th eo t h e rh a dt h es a m es u b s t i t u t i o n sa sa b o v ea tr e s i d u e s7 1
and 84. In order to define the haplotype of the last subject,
her husband and two children were analyzed. The husband
showed pattern 1 for immunoblotting and homozygosity for
the wild-type sequence, while both children showed pattern
2 and heterozygosity for residue 84 substitution (Figure 2).
Therefore, the proband showing two substitutions may have
one allele with
71Tyr and
84Leu and the other with
71Cys and
84Ser.
Sincesubstitutionswerenotfoundintheotherexons,the
twoS NP sinex o n4wer ea nalyzedf o rther ema iningsub jects.
The percentage of glycosylated form (%G) and plasma SAA4
concentrations was compared among the groups showing
eachpolymorphism(Figure 3).Themean%Gofsubjectswith
wild type, those with a
71Tyr substitution, and those with a
84Ser substitution was 24.1%, 50.5%, and 53.1%, respectively.
The %G with either substitution was significantly (𝑃 < 0.05)
higher than that of the wild type. No difference in %G was
notedbetweensubstitutionsof
71Tyr and
84Ser.Therewasalso
no difference in SAA4 concentration among the groups.
4. Discussion
This study revealed that polymorphism of SAA4 influenced
glycosylation efficiency. N-glycosylation is a phenomenon in
which an oligosaccharide is linked to the asparagine side
chain by oligosaccharyl transferase. The structural environ-
ment around asparagine may thus determine the glycosy-
lation efficiency by altering the access of oligosaccharide
or oligosaccharyl transferase. However, since the tertiary
structure of SAA4 has not been elucidated yet, discussion
cannot go beyond speculation. It has been postulated that
the unfolding of polypeptide chains is required in order toBiochemistry Research International 3
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Figure 3: The percent glycosylation (%G) of SAA4 (a) and SAA4 concentration (b) by genotype. W: wild type, 71: with an allele with
71Cys,
84: with an allele with
84Leu, and 71/84: with both alleles. Number of subjects is shown in parentheses.
expose appropriate asparagine sites for carbohydrate attach-
ment [11]. Indeed, the computer-based secondary structure
predictions (PSIPRED and GOR4 methods) indicate that the
N-glycosylation site in the SAA4 molecule adopts a random
coilconformationirrespectiveoftheaminoacidsubstitutions
at residues 71 and 84 [12, 13]. Conformational differences
induced by the amino acid substitutions existed only in the
possible helical regions adjacent to the N-glycosylation site.
Such differences may affect the size and flexibility of the
unfolded N-glycosylation site, which leads to the differences
in the efficiency of glycosylation.
SAA4 is a constitutiveapolipoproteinof HDL.Its physio-
logicalfunctionisvirtuallyunknown.Theplasmaconcentra-
tion of SAA4 varies between individuals and has no relation-
shipwithothermajorapolipoproteins[9].Wereportedprevi-
ouslythatSAA4couldbeminimallyinducedininflammatory
conditions [14]. If it plays a role in inflammation, the glyco-
sylation status of SAA4 may have functional implications.
Inapreviousstudy ,wereportedthatSAA1polymorphism
influenced SAA concentrations (specifically A-SAA concen-
trations) [15]. One of the reasons for this may be that SAA
polymorphism affects the affinity of SAA to HDL followed
by changes in plasma clearance, which was suggested by our
experiments using recombinant SAA1 isotypes [16, 17]. The
present study showed that polymorphism affecting glycosy-
lation did not influence SAA4 concentration, suggesting that
glycosylationmaynotplayanactiveroleinSAA4metabolism
at a level sufficient to affect plasma concentration. However,
it may be worth investigating the interaction between SAA4
a n dH D l ,f o c u s i n go nS A A 4p o l y m o r p h i s ma n di t sr e l a t e d
glycosylationstatus.Itmaybeatriggerthatcanprovideahint
on SAA4 function.
In conclusion, glycosylation of SAA4 was revealed to be
influencedbypolymorphism.Itsbiologicalsignificance,toge-
therwiththebiologicalfunctionofSAA4,needstobefurther
investigated.
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